UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
GemVax wins patent for personalized-tissue engineered vein technology
GemVax Technology, a subsidiary of GemVax & KAEL, said Monday that it has a...
by Lee Han-soo
|
2017-12-19 16:16
라인
Will Takeda, Dong-A ST benefit from new hypertension guideline?
As Takeda Pharmaceuticals Korea is about to release its angiotensin recepto...
by Nam Doo-hyun
|
2017-12-19 16:15
라인
Allergan, Gedeon Richter prove efficacy of bipolar drug in pivotal trial
Allergan and Gedeon Richter are one step closer to getting an expanded FDA ...
by Marian Chu
|
2017-12-19 15:26
라인
New migraine drugs prepare to hit domestic market
New migraine drugs have recently obtained approvals for local clinical tria...
by Lee Hye-seon
|
2017-12-19 15:26
라인
AstraZeneca aims to make Tagrisso 1st-line lung cancer therapy
AstraZeneca is trying hard to make its tyrosine kinase inhibitor Tagrisso a...
by Marian Chu
|
2017-12-19 14:36
라인
Boehringer Ingelheim Korea’s labor union protests early retirement program
The labor union of Boehringer Ingelheim Korea said the company’s recent ann...
by Nam Doo-hyun
|
2017-12-19 14:35
라인
Daehwa Pharma launches clinical trial for breast cancer treatment
Daehwa Pharmaceuticals said that it has launched phase 2/3 clinical trials ...
by Lee Han-soo
|
2017-12-18 16:59
라인
Green Cross unveils non-clinical trial data for hemophilia A treatment
Green Cross said Monday that it has presented non-clinical trial data for M...
by Lee Han-soo
|
2017-12-18 15:12
라인
Kwangdong punished for illegal ad of obesity drug
Kwangdong Pharmaceutical has received an administrative penalty for illegal...
by Lee Hye-seon
|
2017-12-18 14:50
라인
Yuhan’s chemo combo YH24931 more effective than immunotherapy alone
Yuhan Corp.’s combination of chemotherapy with immunotherapy YH24931 has st...
by Nam Doo-hyun
|
2017-12-18 11:51
라인
‘Postmenopausal women in 50s shouldn’t take phytoestrogen’
Over-the-counter drugs and health functional foods to alleviate symptoms of...
by Nam Doo-hyun
|
2017-12-18 10:49
라인
3 Korean startups using AI to develop new drugs
Korea’s biopharmaceutical industry is increasingly adopting artificial inte...
by Marian Chu
|
2017-12-15 23:00
라인
Medytox, Hugel compete in botulinum toxin market
Medytox and Hugel have achieved a rapid growth in manufacturing botulinum t...
by So Jae-hyeon
|
2017-12-15 15:12
라인
Parkinson’s disease treatment Azilect in robust growth
Lundbeck Korea’s Azilect (ingredient: rasagiline) is performing well in Kor...
by So Jae-hyeon
|
2017-12-15 11:36
라인
Ildong, Abbot to tap rosuvastatin+ezetimibe combo market
Ildong Pharmaceutical and Abbot Korea are likely to try on the rosuvastatin...
by Lee Hye-seon
|
2017-12-14 15:01
라인
Koreans in their 20s most susceptible to hepatitis A: study
New research shows nine out of 10 young adults in Korea do not have antibod...
by Marian Chu
|
2017-12-13 18:18
라인
MGmed to change name to Cancer Rop
Korean pharmaceutical MGmed decided to change the company’s name to Cancer ...
by Marian Chu
|
2017-12-13 18:14
라인
Syntekabio, CJ Healthcare agree to develop new drugs using AI
Syntekabio and CJ Healthcare have signed an agreement to co-develop a new i...
by Lee Han-soo
|
2017-12-13 17:17
라인
Daewoong’s liver drug Ursa to enter US market
Daewoong Pharmaceutical said it aimed to sell its flagship product Ursa, a ...
by So Jae-hyeon
|
2017-12-13 15:23
라인
Janssen says its multiple myeloma drug combo halves death risk
Janssen, a Johnson & Johnson division, said a combination therapy with DARZ...
by Marian Chu
|
2017-12-13 15:22
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top